Type 2 diabetes mellitus is becoming an increasing problem among children and adolescents.1,2 Type 1 diabetes mellitus is caused by deficiency of insulin secretion from pancreatic beta-cell damage. Type 1A is characterized by autoimmune destruction of pancreatic beta cells; type 1B refers to insulin-dependent diabetes not of immune cause. Type 2 diabetes occurs most often in adults and is associated with insulin resistance and a relative insufficiency of insulin.
In the past, 2% to 3% children with diabetes were thought to have type 2 disease.3 However, an increasing number of cases are being seen in pediatric clinics and in the general population. This increase in frequency is linked to the increase in childhood obesity. A study in 2000 from Ohio showed that 33% of African American and Caucasian children aged 10 to 19 years with diabetes had type 2 disease.4 It has been estimated that 4.1 per 1000 American children aged 12 to 19 years have diabetes and that 30% of these children have type 2 diabetes.5
Type 2 diabetes in children is associated with obesity, family history of type 2 diabetes, female sex, and ethnic background.4 In Canada, various aboriginal communities have been studied. One study found a high prevalence of childhood obesity that resulted in an increased risk of diabetes or impaired fasting glucose.6 Among the risk factors described, childhood obesity is the only one that can be altered and therefore should be the target for prevention strategies.
The early onset of type 2 diabetes is a serious health concern for children, since a significant portion of their life will be spent controlling this disease. Complications of diabetes are common; poor glycemic control of long duration can lead to significant morbidity, including macrovascular (peripheral vascular disease, coronary artery disease, and stroke) and microvascular (retinopathy, neuropathy, and nephropathy) complications.7 Obesity in itself can also lead to macrovascular complications and hypertension.
The new challenge to physicians is to prevent these problems from occurring through aggressive management of childhood obesity. Here we provide guidelines on detecting type 2 diabetes and on close monitoring of children with the disease.
Diagnosis of Type 2 Diabetes in Children
It has been recommended that the fasting (no food for at least 8 hours) plasma glucose be used for the initial screening test. The test is fast, easy to perform, inexpensive, and more convenient than the oral glucose tolerance test.
75-g oral glucose tolerance test may be necessary when clinical suspicion is high but the fasting plasma glucose level is normal. With the oral glucose tolerance test, a 2-hour blood glucose value of 11.1 mmol/L or higher is considered a positive result for diabetes, 7.8 to 11 mmol/L is impaired glucose tolerance, and less than 7.8 mmol/L is normal. In the absence of significant symptoms and unequivocal metabolic decompensation, a confirmatory laboratory glucose test (either a fasting plasma glucose, casual plasma glucose or oral glucose tolerance test) must be done on a separate day.9
Children, like adults, may be asymptomatic for a long period before presenting with signs or symptoms of hyperglycemia in type 2 diabetes. Although diabetic ketoacidosis is commonly seen in type 1 diabetes, children with type 2 diabetes may present with diabetic ketoacidosis.10
Children should be screened for type 2 diabetes if they have a family history of type 2 diabetes, are from a high-risk ethnic group, are obese, or have polycystic ovary syndrome. Important historical and physical examination findings and laboratory investigations are shown in Tables 1, 2, and 3.
1. Rosenbloom AL. Increasing incidence of type 2 diabetes in children and adolescents: treatment considerations. Paediatr Drugs. 2002;4:209-221.
2. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22:345-354.
3. Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am. 1997;44:307-337.
4. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr. 2000;136:664-672.
5. Silverstein JH, Rosenbloom AL. Type 2 diabetes in children. Curr Diab Rep. 2001;1:19-27.
6. Young TK, Dean HJ, Flett B, Wood-Steiman P. Childhood obesity in a population at high risk for type 2 diabetes. J Pediatr. 2000;136:365-369.
7. Fore WW. Noninsulin-dependent diabetes mellitus. The prevention of complications. Med Clin North Am. 1995;79:287-298.
8. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S7-S9.
9. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S10-S13.
10. Valabhji J, Watson M, Cox J, et al. Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med. 2003;20:416-417.
11. McKnight-Menci H, Sababu S, Kelly SD. The care of children and adolescents with type 2 diabetes. J Pediatr Nurs. 2005;20:96-106.
12. Granberry MC, Fonseca VA. Insulin resistance syndrome: options for treatment. South Med J. 1999; 92:2-15.
13. Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2002;25:89-94.
14. Zuhri-Yafi MI, Brosnan PG, Hardin DS. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metabol. 2002;15 (suppl 1):541-546.
15. Silverstein JH, Rosenbloom AL. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metabol. 2000;13(suppl 6): 1403-1409.
16.Sellers EA, Dean JH. Short-term insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metabol. 2004;17:1561-1564.
17. Ditmyer MM, Price JH, Telljohann SK, Rogalski F. Pediatricians' perceptions and practices regarding prevention and treatment of type 2 mellitus in children and adolescents. Arch Pediatr Adolesc Med. 2003;157:913-918.
18. Pacaud D. The growing problem of childhood obesity: what can be done about the epidemic? DC Paediatric Nutrition. 2003;1:9-12.